EGFR and lung carcinoma: Significantly, DUSP22 failed to inhibit colony formation in EGFRlow H520 and TC-1 cells (Fig. S2D), suggesting that DUSP22 predominantly acts on EGFR and hinders EGFR signaling to impede lung cancer cell proliferation via dephosphorylation, regardless of their EGFR mutation status.